Fig. 1
From: The prognostic value of neuromedin U in patients with hepatocellular carcinoma
IL-25 is highly expressed in HCC patients. a The level of NMU were detected by ELISA in serum of hepatic hemangioma patients (n = 10) and HCC patients (n = 10). b Immunohistochemistry (IHC) staining was performed in a tissue microarray consisted of 228 HCC peri- and intra-tumor tissue, NMU representative IHC images are shown. Bar, 20 μm. ** p < 0.01. NMU, neuromedin U; HH, hepatic hemangioma; HCC, hepatocellular carcinoma